The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR

被引:62
|
作者
Wang, Won-Jing
Kuo, Jean-Cheng
Ku, Wei
Lee, Yu-Ru
Lin, Feng-Chi
Chang, Yih-Leong
Lin, Yu-Min
Chen, Chun-Hau
Huang, Yuan-Ping
Chiang, Meng-Jung
Yeh, Sheng-Wen
Wu, Pei-Rung
Shen, Che-Hung
Wu, Chen-Tu
Chen, Ruey-Hwa [1 ]
机构
[1] Acad Sinica, Inst Biol Sci, Taipei 115, Taiwan
[2] Natl Taiwan Univ, Inst Mol Med, Taipei 115, Taiwan
[3] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei 115, Taiwan
[4] Natl Taiwan Univ, Inst Biochem Sci, Taipei 115, Taiwan
关键词
D O I
10.1016/j.molcel.2007.06.037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Death-associated protein kinase (DAPK) is a calmodulin-regulated serine/threonine kinase and elicits tumor suppression function through inhibiting cell adhesion/migration and promoting apoptosis. Despite these biological functions, the signaling mechanisms through which DAPK is regulated remain largely elusive. Here, we show that the leukocyte common antigen-related (LAR) tyrosine phosphatase dephosphorylates DAPK at pY491/492 to stimulate the catalytic, proapoptotic, and antiadhesion/antimigration activities of DAPK. Conversely, Src phosphorylates DAPK at Y491/492, which induces DAPK intra-/intermolecular interaction and inactivation. Upon EGF stimulation, a rapid Src activation leads to subsequent LAR down-regulation, and these two events act in synergism to inactivate DAPK, thereby facilitating tumor cell migration and invasion toward EGF. Finally, DAPK Y491/492 hyperphosphorylation is found in human cancers in which Src activity is aberrantly elevated. These results identify LAR and Src as a DAPK regulator through their reciprocal modification of DAPK Y491/492 residues and establish a functional link of this DAPK-regulatory circuit to tumor progression.
引用
收藏
页码:701 / 716
页数:16
相关论文
共 50 条
  • [31] The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-β pathway
    Takahashi, Mariko
    Lio, Chan-Wang J.
    Campeau, Anaamika
    Steger, Martin
    Ay, Ferhat
    Mann, Matthias
    Gonzalez, David J.
    Jain, Mohit
    Sharma, Sonia
    NATURE IMMUNOLOGY, 2021, 22 (04) : 485 - +
  • [32] Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1
    Si, Yuan
    Ji, Xinyan
    Cao, Xiaolei
    Dai, Xiaoming
    Xu, Lingyi
    Zhao, Hongxia
    Guo, Xiaocan
    Yan, Huan
    Zhang, Haitao
    Zhu, Chu
    Zhou, Qi
    Tang, Mei
    Xia, Zongping
    Li, Li
    Cong, Yu-Sheng
    Ye, Sheng
    Liang, Tingbo
    Feng, Xin-Hua
    Zhao, Bin
    CANCER RESEARCH, 2017, 77 (18) : 4868 - 4880
  • [33] The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING–IFN-β pathway
    Mariko Takahashi
    Chan-Wang J. Lio
    Anaamika Campeau
    Martin Steger
    Ferhat Ay
    Matthias Mann
    David J. Gonzalez
    Mohit Jain
    Sonia Sharma
    Nature Immunology, 2021, 22 : 485 - 496
  • [34] The fast gate of CFTR is regulated by the tyrosine kinase p60(c-src).
    Fischer, H
    Machen, TE
    FASEB JOURNAL, 1996, 10 (03): : 533 - 533
  • [35] ASSOCIATION OF THE TYROSINE KINASE PP60SRC WITH THE CORE CYTOSKELETON AND SLOW TYROSINE PHOSPHORYLATION ARE REGULATED BY AGGREGATION AGGLUTINATION
    ODA, A
    DRUKER, B
    SMITH, M
    SALZMAN, EW
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 730 - 730
  • [36] Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation
    Gronda, M
    Arab, S
    Iafrate, B
    Suzuki, H
    Zanke, BW
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (20) : 6851 - 6858
  • [37] Receptor Protein Tyrosine Phosphatase-Receptor Tyrosine Kinase Substrate Screen Identifies EphA2 as a Target for LAR in Cell Migration
    Lee, Hojin
    Bennett, Anton M.
    MOLECULAR AND CELLULAR BIOLOGY, 2013, 33 (07) : 1430 - 1441
  • [38] Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity
    Middendorp, S
    Zijlstra, AJE
    Kersseboom, R
    Dingjan, GM
    Jumaa, H
    Hendriks, RW
    BLOOD, 2005, 105 (01) : 259 - 265
  • [39] STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression
    Zhang, Qian
    Wang, Hong Y.
    Liu, Xiaobin
    Wasik, Mariusz A.
    NATURE MEDICINE, 2007, 13 (11) : 1341 - 1348
  • [40] Loss of Tyrosine Phosphatase-Dependent Inhibition Promotes Activation of Tyrosine Kinase c-Src in Detached Pancreatic Cells
    Connelly, Sarah F.
    Isley, Beth A.
    Baker, Cheryl H.
    Gallick, Gary E.
    Summy, Justin M.
    MOLECULAR CARCINOGENESIS, 2010, 49 (12) : 1007 - 1021